Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 108,848 | 62,676 | 52,681 | 67,378 | 67,669 |
| Marketable Securities | 241,782 | 286,845 | 293,776 | 293,846 | 323,630 |
| Receivables | 44,071 | 45,473 | 50,847 | 47,720 | 40,399 |
| Inventories | 10,294 | 9,703 | 8,218 | N/A | N/A |
| Income taxes - deferred | 7,786 | 10,469 | 9,790 | 4,427 | 9,524 |
| TOTAL | $432,437 | $418,479 | $418,261 | $415,606 | $444,812 |
| Non-Current Assets | |||||
| PPE Net | 24,329 | 23,259 | 23,080 | 21,343 | 22,905 |
| Investments And Advances | 77,629 | 52,182 | 70,857 | 90,267 | 103,106 |
| Intangibles | 73,115 | 73,290 | 72,766 | 0 | 0 |
| Other Non-Current Assets | 53,748 | 52,525 | 25,863 | 30,064 | 22,786 |
| TOTAL | $228,821 | $201,256 | $192,566 | $141,674 | $148,797 |
| Total Assets | $661,258 | $619,735 | $610,827 | $557,280 | $593,609 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,876 | 9,827 | 11,395 | 5,191 | 7,050 |
| Accrued Expenses | 23,736 | 20,383 | 21,645 | 18,181 | 16,138 |
| TOTAL | $35,046 | $31,293 | $34,387 | $23,372 | $23,188 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,434 | 1,083 | 1,347 | N/A | N/A |
| Other Non-Current Liabilities | 9,448 | 9,448 | 9,648 | 9,448 | 9,320 |
| TOTAL | $9,448 | $9,448 | $9,648 | $9,448 | $9,320 |
| Total Liabilities | $44,494 | $40,741 | $44,035 | $32,820 | $32,508 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,288 | 84,728 | N/A | 85,736 | 89,881 |
| Common Shares | 842 | 846 | 862 | 857 | 901 |
| Retained earnings | -21,430 | -38,299 | -38,630 | -48,082 | -20,661 |
| Other shareholders' equity | -253 | -113 | 151 | 100 | 99 |
| TOTAL | $616,764 | $578,994 | $566,792 | $524,460 | $561,101 |
| Total Liabilities And Equity | $661,258 | $619,735 | $610,827 | $557,280 | $593,609 |